4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid

C174H222N28O16 — CID 157455639

About 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid

4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (PubChem CID 157455639) has the molecular formula C174H222N28O16 and a molecular weight of 2961.87 g/mol. Its IUPAC name is 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.

Molecular Properties

• Compound Name: 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
• PubChem CID: 157455639
• Molecular Formula: C174H222N28O16
• Molecular Weight: 2961.87 g/mol
• Exact Mass: 2959.74
• IUPAC Name: 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid
• SMILES: CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)NCCCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@@H](c1ccccc1)N1CCN(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)NCCCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)NCCC3)C1
• InChI: InChI=1S/C26H34N4O3.C26H34N4O2.2C25H32N4O2.C24H30N4O3.2C24H30N4O2/c1-19(31)23(20-7-3-2-4-8-20)30-17-13-26(33,14-18-30)25(32)28-16-6-10-22-12-11-21-9-5-15-27-24(21)29-22;1-20(31)25(21-8-3-2-4-9-21)30-18-16-29(17-19-30)24(32)12-6-5-11-23-14-13-22-10-7-15-27-26(22)28-23;2*1-18(30)23(19-8-3-2-4-9-19)29-16-21(17-29)25(31)27-14-6-5-11-22-13-12-20-10-7-15-26-24(20)28-22;29-23(26-14-5-9-20-11-10-18-8-4-13-25-22(18)27-20)19-12-15-28(16-19)21(24(30)31)17-6-2-1-3-7-17;2*1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20/h2-4,7-8,11-12,23,33H,5-6,9-10,13-18H2,1H3,(H,27,29)(H,28,32);2-4,8-9,13-14,25H,5-7,10-12,15-19H2,1H3,(H,27,28);2*2-4,8-9,12-13,21,23H,5-7,10-11,14-17H2,1H3,(H,26,28)(H,27,31);1-3,6-7,10-11,19,21H,4-5,8-9,12-16H2,(H,25,27)(H,26,29)(H,30,31);2*2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30)/t;25-;2*23-;19-,21?;2*23-/m.010010/s1
• InChIKey: BTIBLISRVKJJQU-GWKKOSDQSA-N
• XLogP: 20.98
• TPSA: 551.98 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 36
• Rotatable Bonds: 58
• Heavy Atoms: 218
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2961.87
LogP ≤ 5	20.98
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	36

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The IUPAC name of 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid (CID 157455639) is 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid.

What is the SMILES notation for 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The canonical SMILES for 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is CC(=O)C(c1ccccc1)N1CCC(O)(C(=O)NCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@@H](c1ccccc1)N1CC(C(=O)NCCCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@@H](c1ccccc1)N1CCN(C(=O)CCCCc2ccc3c(n2)NCCC3)CC1.CC(=O)[C@H](c1ccccc1)N1CC(C(=O)NCCCCc2ccc3c(n2)NCCC3)C1.CC(=O)[C@H](c1ccccc1)N1CC(NC(=O)CCCc2ccc3c(n2)NCCC3)C1.O=C(O)C(c1ccccc1)N1CC[C@H](C(=O)NCCCc2ccc3c(n2)NCCC3)C1.

What is the InChIKey of 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

The InChIKey is BTIBLISRVKJJQU-GWKKOSDQSA-N. The full InChI is InChI=1S/C26H34N4O3.C26H34N4O2.2C25H32N4O2.C24H30N4O3.2C24H30N4O2/c1-19(31)23(20-7-3-2-4-8-20)30-17-13-26(33,14-18-30)25(32)28-16-6-10-22-12-11-21-9-5-15-27-24(21)29-22;1-20(31)25(21-8-3-2-4-9-21)30-18-16-29(17-19-30)24(32)12-6-5-11-23-14-13-22-10-7-15-27-26(22)28-23;2*1-18(30)23(19-8-3-2-4-9-19)29-16-21(17-29)25(31)27-14-6-5-11-22-13-12-20-10-7-15-26-24(20)28-22;29-23(26-14-5-9-20-11-10-18-8-4-13-25-22(18)27-20)19-12-15-28(16-19)21(24(30)31)17-6-2-1-3-7-17;2*1-17(29)23(18-7-3-2-4-8-18)28-15-21(16-28)26-22(30)11-5-10-20-13-12-19-9-6-14-25-24(19)27-20/h2-4,7-8,11-12,23,33H,5-6,9-10,13-18H2,1H3,(H,27,29)(H,28,32);2-4,8-9,13-14,25H,5-7,10-12,15-19H2,1H3,(H,27,28);2*2-4,8-9,12-13,21,23H,5-7,10-11,14-17H2,1H3,(H,26,28)(H,27,31);1-3,6-7,10-11,19,21H,4-5,8-9,12-16H2,(H,25,27)(H,26,29)(H,30,31);2*2-4,7-8,12-13,21,23H,5-6,9-11,14-16H2,1H3,(H,25,27)(H,26,30)/t;25-;2*23-;19-,21?;2*23-/m.010010/s1.

What are the key properties of 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid?

4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid has a molecular weight of 2961.87 g/mol, XLogP of 20.98, 58 rotatable bonds, 15 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 4-hydroxy-1-(2-oxo-1-phenylpropyl)-N-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]piperidine-4-carboxamide;N-[1-[(1S)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;N-[1-[(1R)-2-oxo-1-phenylpropyl]azetidin-3-yl]-4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanamide;1-[4-[(1R)-2-oxo-1-phenylpropyl]piperazin-1-yl]-5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentan-1-one;1-[(1R)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;1-[(1S)-2-oxo-1-phenylpropyl]-N-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]azetidine-3-carboxamide;2-phenyl-2-[(3S)-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propylcarbamoyl]pyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 157455639), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).